Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment involves in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment involves in the sale of precision oncology testing services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.